Anemia, Hypochromic: Clinical Trials

102 trials for Anemia, Hypochromic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 23 unknown, 9 recruiting, 9 terminated. 102 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4102Completed 47, Unknown 23, Recruiting 9, Terminated 9, Not yet recruiting 7, Withdrawn 6, Suspended 1

Follow Anemia, Hypochromic: new trials by email Literature Review of Anemia, Hypochromic trials Research Report on Anemia, Hypochromic

Trials (filtered) newest first · largest first

All 102 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Daily Iron vs Every-other-day Iron for Pediatric Patients With IDA
iron sulfate - Iron Deficiency Anemia
Phase 4Not yet recruitingLoma Linda University1002026-12-012026-07-10
Sucrosomial Vs Intravenous Iron for Preoperative Anemia
Treatment with oral sucrosomial iron, Treatment with intravenous iron - Anemia, Iron Deficiency Anemia
Phase 4WithdrawnUniversity of Rochester2026-12-012026-10-06
Ferric Carboxymaltose Versus Iron Sucrose for Iron Deficiency Anemia After Radical Gastrectomy for Gastric Cancer
Ferric Carboxymaltose (FCM), Iron Sucrose. - Gastric Cancer (GC), Iron Deficiency Anemia (IDA)
Phase 4Not yet recruitingZhaojian Niu,MD1602026-08-012026-08-19
Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy
INTRAVENOUS FERRIC CARBOXYMALTOSE, oral iron therapy - Postpartum Fatigue, Iron Deficiency Anemia
Phase 4CompletedPakistan Air Force (PAF) Hospital Islamabad1342026-04-202026-10-19
Alternate-day Versus Daily Oral Iron Therapy in Children With Iron Deficiency Anaemia
Alternate-day oral Iron (III)-hydroxide polymaltose complex, Iron (III)-hydroxide polymaltose complex - daily oral dosing Iron (III)-hydroxide polymaltose complex - alternate-day oral dosing - Iron Deficiency Anemia
Phase 4Not yet recruitingUniversity of Medicine, Mandalay602026-02-012026-02-05
The Role of Ferric Carboxymaltose in the Treatment of Pediatric Iron Deficiency Anemia in the Emergency Department
Ferric Carboxymaltose (FCM), Ferrous Sulfate - Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease, Iron Deficiency Anaemia Due to Dietary Causes
Phase 4Not yet recruitingChildren's Hospital of Orange County1502026-01-312026-02-17
Acupoint TENS vs Resistance Training for Iron Deficiency Anemia
Acupuncture transcutaneous electrical nerve stimulation (Acu-TENS), Resistance exercise training, Ferrous Sulfate - Iron Deficiency Anemia
Phase 4RecruitingCairo University602026-01-152026-05-26
Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Sucrosomial® Iron (Sideral® Forte), Ferric Maltol (Feraccru®) - Anemia, Iron Deficiency Anemia (IDA)
Phase 4RecruitingPharmanutra S.p.a.1462025-12-112026-09-03
Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery
Ferric derisomaltose, Placebo (0.9% saline) - Anemia, Iron Deficiencies
Phase 4Not yet recruitingYonsei University1802025-12-012025-11-20
Oral Iron Supplementation on Alternate vs. Consecutive Days for Iron Deficiency Anemia in Pregnancy
daily ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill, alternate day ferrous sulfate with an equivalent elemental iron dose of 65 mg per pill - Iron-deficiency Anemia (IDA), Pregnancy
Phase 4RecruitingSouthern Illinois University1202025-05-272026-04-24
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Ferric Carboxymaltose, Ferrous Sulfate - Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 4TerminatedSyed Hamza Mufarrih422025-04-022026-07-20
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure
Sucrosomial iron, Placebo - Chronic Heart Failure, Iron-deficiency
Phase 4RecruitingRaffaele De Caterina602024-03-142025-10-01
Optimizing Dosing Strategies in Oral Iron Supplementation
Tardyferon - Iron Deficiencies, Iron Deficiency Anemia
Phase 4CompletedLuzerner Kantonsspital292024-03-012026-01-07
Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy
Ferrous Sulfate Oral Product - Cerebral Palsy, Iron Deficiency Anemia
Phase 4UnknownShaheed Zulfiqar Ali Bhutto Medical University1602024-02-012024-01-17
Ferric Carboxymaltose Versus Iron Sucrose for Treating Anemia in Pregnant Women
Iron Carboxymaltose, Iron Sucrose Injection - Iron Deficiency Anemia (IDA), Pregnancy
Phase 4CompletedCMH Multan Institute of Medical Sciences602024-02-012025-04-06
Effects of IV Iron Replacement on Exercise Capacity in Individuals With Heart Failure
IV Iron Infusion Group - Heart Failure, Iron-deficiency
Phase 4TerminatedRadha Gopalan62024-01-242026-07-29
Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency
Sucrosomial iron, Vitamin D, Ferric Carboxymaltose 50 MG/ML - Heart Failure, Iron-deficiency
Phase 4UnknownUniversity of Padova2582024-01-152023-12-15
Iron Deficiency Anemia (IDA) and the Brain
Ferric derisomaltose, NovaFerrum - IDA - Iron Deficiency Anemia, Anemia
Phase 4RecruitingChildren's Hospital Los Angeles1202023-12-072024-10-30
Comparison Between Outcomes of Pregnant Women Treated With Ferinject vs. Venofer for Iron Deficiency Anemia
Venofer 200 MG Per 10 ML Injection, Ferinject - Anemia, Iron Deficiency, Pregnancy Anemia
Phase 4RecruitingWestern Galilee Hospital-Nahariya2002023-11-022026-09-11
Iron Treatment for Iron Deficiency Anemia in Children and Young Adults With Crohn's Disease
Iron (ferrous sulfate) - Crohn's Disease, Iron Deficiency Anemia
Phase 4RecruitingWeill Medical College of Cornell University1502023-09-132026-11-09

Showing 20 of 102. Sign in to see all of them.

Narrower conditions

Anemia, Iron-Deficiency (102)  ·  Anemia (24)  ·  Iron Deficiencies (18)  ·  Heart Failure (9)  ·  Renal Insufficiency, Chronic (9)  ·  Kidney Failure, Chronic (5)  ·  Renal Insufficiency (3)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Colorectal Neoplasms (2)  ·  Crohn Disease (2)  ·  Fatigue (2)  ·  Inflammation (2)  ·  Inflammatory Bowel Diseases (2)  ·  Menorrhagia (2)  ·  Pregnancy Complications (2)

Broader conditions

Hemic and Lymphatic Diseases (102)  ·  Iron Metabolism Disorders (102)  ·  Metabolic Diseases (102)  ·  Nutritional and Metabolic Diseases (102)  ·  Hematologic Diseases (101)  ·  Iron Deficiencies (84)  ·  Anemia (78)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Female Urogenital Diseases and Pregnancy Complications (18)  ·  Urogenital Diseases (18)  ·  Female Urogenital Diseases (15)  ·  Pathologic Processes (15)  ·  Male Urogenital Diseases (13)  ·  Urologic Diseases (13)

Interventions

ferric carboxymaltose (27)  ·  ferrous sulfate (18)  ·  Iron-Dextran Complex (14)  ·  Ferric Oxide, Saccharated (9)  ·  Iron (8)  ·  Sodium Chloride (7)  ·  Ferrosoferric Oxide (5)  ·  ferric gluconate (5)  ·  Lactoferrin (4)  ·  ferric derisomaltose (4)  ·  ferric maltol (4)  ·  ferrous fumarate (4)  ·  ferryl iron (3)  ·  iron isomaltoside 1000 (3)  ·  sucrosomial iron (3)

Sponsors

Ain Shams University (4)  ·  Watson Pharmaceuticals (4)  ·  Thomas Jefferson University (3)  ·  University of Zurich (3)  ·  American Regent, Inc. (2)  ·  Assiut University (2)  ·  Cairo University (2)  ·  Hannover Medical School (2)  ·  South Valley University (2)  ·  AMAG Pharmaceuticals, Inc. (1)  ·  Albina Nowak, MD (1)  ·  American University of Beirut Medical Center (1)  ·  Baylor College of Medicine (1)  ·  CMH Multan Institute of Medical Sciences (1)  ·  Cantonal Hospital, Baselland (1)

Countries

United States (26)  ·  Egypt (10)  ·  Switzerland (8)  ·  Germany (4)  ·  Netherlands (4)  ·  Canada (3)  ·  India (3)  ·  Italy (3)  ·  Pakistan (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Greece (2)  ·  Israel (2)  ·  Lebanon (2)  ·  Puerto Rico (2)

Top investigators

Adel R. Rizkala, Pharm.D., MS (2)  ·  Abdel-Latif G. El-Kholy, Ass. Prof. (1)  ·  Adel R Rizkala, PharmD, MS (1)  ·  Ahmed Elshahawy, MD (1)  ·  Ahmed Gaber Ahmed (1)  ·  Ahmed Kamel, M.D. (1)  ·  Albert Kheradpour, MD (1)  ·  Albina Nowak, MD (1)  ·  Alexander Krafft, MD (1)  ·  Alfred Jacobs, MD (1)  ·  Ana Varea, Biochemist (1)  ·  Andrius Macas, MDPhDProf (1)  ·  Anna T Valson, MD, DM (1)

Results publications

PMID 11796024, PMID 15824508, PMID 17035697, PMID 17267740, PMID 17396118, PMID 17620512, PMID 17622274, PMID 17962803, PMID 18216316, PMID 19034302, PMID 19212255, PMID 20147465, PMID 20715601, PMID 20819898, PMID 21982521, PMID 22071701, PMID 22456661, PMID 22492366, PMID 23230066, PMID 23505057, PMID 24590680, PMID 25119339, PMID 25406528, PMID 26192787, PMID 26394823, PMID 26864367, PMID 27557596, PMID 28372549, PMID 28382661, PMID 28609534, PMID 28612425, PMID 28659293, PMID 29607528, PMID 30051186, PMID 30298070, PMID 30802204, PMID 30853478, PMID 32067585, PMID 32331365, PMID 32654663, PMID 32801202, PMID 33136134, PMID 33673371, PMID 34710946, PMID 34913362, PMID 35301854, PMID 35363499, PMID 35706490, PMID 35956390, PMID 36375780

NIH funding

2016 (2), 2015 (1), 2018 (1), 2023 (1), 2025 (1), R01NS117430 (1), U01DK071633 (1)